1 Center for Outcomes Research and Evaluation, Research Institute of McGill University Health Center, Montreal, QC, Canada.
2 Department of Surgery/Transplant, Yale University School of Medicine, New Haven, CT.
3 Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
4 Transplantation Immunology Unit, Padua University Hospital, Padova, Italy.
5 Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY.
6 Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
7 McGill University Health Centre Medical Libraries, Montreal, QC, Canada.
8 Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
9 Department of Pathology and Lab Medicine, Baylor University Medical Center, Dallas, TX.
10 Department of Lab Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
11 Weill Cornell Medicine—New York Presbyterian Hospital, New York, NY.
12 Medstar Georgetown Transplant Institute, Washington, DC.
13 Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
14 Division of Nephrology and Multi-Organ Transplant Program, Department of Medicine, McGill University, Montreal, QC, Canada.
Received 11 March 2022. Revision received 4 May 2022.
Accepted 18 May 2022.
R.S.-P. is supported by a Fonds de recherche du Quebec—Santé chercheur boursier clinicien award (grant no. 254386) and a Genome Canada Large Scale Applied Research Program Award “Precision Medicine CanPREVENT AMR” funded by Genome Quebec, Genome British Columbia, Genome Alberta, and Canadian Institutes of Health Research (LSARP 273AMR and GP1-155871). M.N. is senior clinical investigator of the Research Foundation – Flanders (FWO) (grant no. 1844019N).
The authors declare no conflicts of interest.
The study design was conducted by L.M.B., E.C., E.S.K., I.B., and R.S.-P. Performance of research or data analysis was conducted by L.M.B., E.C., S.S.J., H.Z., T.H., A.A.-Z., I.B., C.S., D.M.D., E.S.K., R.S.-P. Article drafting was conducted by S.S.J., H.Z., L.M.B., E.C., E.S.K., I.B., and R.S.-P. The critical revision was conducted by S.S.J., H.Z., L.M.B., E.C., E.S.K., I.B., M.A., D.M.D., M.C., M.N., C.S., and R.S.-P.
Supplemental Visual Abstract; https://links.lww.com/TP/C494.
Supplemental digital content (SDC) is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (www.transplantjournal.com).
Correspondence: Ruth Sapir-Pichhadze, MD, PhD, FRCPC, Center for Outcomes Research and Evaluation, Research Institute of the McGill University Health Center, 5252 boul de Maisonneuve, Office 3E.13, Montréal, QC H4A 3S5, Canada. ([email protected]).
